Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment
- 13 August 2008
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 199 (1-2) , 142-150
- https://doi.org/10.1016/j.jneuroim.2008.05.006
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Impairment of endothelial cell differentiation from bone marrow–derived mesenchymal stem cells: New insight into the pathogenesis of systemic sclerosisArthritis & Rheumatism, 2007
- Role of Toll‐Like Receptors on Human Adipose‐Derived Stromal CellsThe International Journal of Cell Cloning, 2006
- Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitroRheumatology, 2006
- The role of mesenchymal stem cells in haemopoiesisBlood Reviews, 2006
- Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsivenessBlood, 2005
- Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood, 2005
- Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivoPublished by Elsevier ,2002
- Mesenchymal stem cellsExperimental Hematology, 2000
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progenyBlood, 1980